Inlightened often partners on such initiatives to source site PIs and sub-Is to oversee the trials. PE: How do such partnerships come to be? Pavone: It’s often an introduction to someone overseeing ...

Inlightened CEO and cofounder Shelli Pavone attributes some of this to a knowledge gap in the industry, or what she sees as a classic mismatch between innovation and need.

BOSTON, June 11, 2025--Inlightened, a tech-enabled insights platform that connects innovative client companies to a network of vetted healthcare professionals (HCPs), today announced the findings ...

Shelli Pavone, co-founder and CEO, Inlightened Shelli Pavone has nearly 20 years of commercial experience in healthcare, and a history of developing sales strategy and teams from the ground up.

It’s become increasingly clear that a lack of diversity in clinical trials is a major issue for the pharmaceutical industry. While the problem has been identified, the industry is still struggling to ...

More than half – 57% – are currently using AI tools at work, such as ambient listening/clinical documentation, billing, chatbots, and diagnostics 26% are using AI tools because they believe ...